Literature DB >> 16424415

Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll.

Barbara Phillips1, Wayne Hening, Pat Britz, David Mannino.   

Abstract

PURPOSES: The purpose of this analysis was to investigate the prevalence and correlates of restless legs syndrome (RLS) symptoms in the 2005 National Sleep Foundation (NSF) Sleep in America 2005 Poll. The NSF poll is an annual telephone interview of a random, representative sample of US adults.
METHODS: The NSF 2005 poll included 1,506 adults. Their mean age was 49 years, and 775 were women.
RESULTS: Symptoms of RLS that included unpleasant feelings in the legs for at least a few nights a week, which were worse at night, were reported by 9.7% of individuals in this poll, including 8% of men and 11% of women. Those from the northeast United States were much less likely to be at risk than those from other regions of the country (p < 0.05). Those who were unemployed (p < 0.05) or smoked daily (p < 0.5) were more likely to be at risk for RLS, as were those with hypertension, arthritis, gastroesophageal reflux disease, depression, anxiety, and diabetes (p < 0.05 for all). Adults who were at risk for RLS appeared to also be at increased risk for sleep apnea and insomnia (p < 0.05), and were more likely to stay up longer than they planned, to take longer than 30 min to fall asleep, to drive when drowsy, and to report daytime fatigue than those who were not at risk (p < 0.05 for all). They were also more likely to report being late to work, missing work, making errors at work, and missing social events because of sleepiness than other respondents in the poll (p < 0.05 for all).
CONCLUSIONS: RLS is significantly associated with medical and psychiatric conditions, other sleep disorders, unfavorable lifestyle behaviors, and adverse effects on daytime function. Chest physicians who practice sleep medicine need to be able to identify and manage RLS, which is prevalent and is associated with considerable morbidity.

Entities:  

Mesh:

Year:  2006        PMID: 16424415     DOI: 10.1378/chest.129.1.76

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  60 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  Restless legs syndrome: relationship between prevalence and latitude.

Authors:  Brian B Koo
Journal:  Sleep Breath       Date:  2011-12-31       Impact factor: 2.816

3.  Use of near-infrared light to reduce symptoms associated with restless legs syndrome in a woman: a case report.

Authors:  Ulrike H Mitchell
Journal:  J Med Case Rep       Date:  2010-08-23

4.  Sleep and hypertension.

Authors:  David A Calhoun; Susan M Harding
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

5.  Development of the National Healthy Sleep Awareness Project Sleep Health Surveillance Questions.

Authors:  Timothy I Morgenthaler; Janet B Croft; Leslie C Dort; Lauren D Loeding; Janet M Mullington; Sherene M Thomas
Journal:  J Clin Sleep Med       Date:  2015-09-15       Impact factor: 4.062

6.  Ropinirole versus placebo in primary restless legs syndrome.

Authors:  John C Morgan; Kapil D Sethi
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

7.  Nature and variants of idiopathic restless legs syndrome: observations from 152 patients referred to secondary care in the UK.

Authors:  R Holmes; S Tluk; V Metta; P Patel; R Rao; A Williams; K R Chaudhuri
Journal:  J Neural Transm (Vienna)       Date:  2007-01-22       Impact factor: 3.575

Review 8.  Prevalence of restless legs syndrome in North American and Western European populations: a systematic review.

Authors:  Kim E Innes; Terry Kit Selfe; Parul Agarwal
Journal:  Sleep Med       Date:  2011-07-12       Impact factor: 3.492

Review 9.  Insomnia: definition, prevalence, etiology, and consequences.

Authors:  Thomas Roth
Journal:  J Clin Sleep Med       Date:  2007-08-15       Impact factor: 4.062

10.  Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management.

Authors:  Magdolna Hornyak
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.